Mirabilis closes $10.5m in series A extension:
This article was originally published in Clinica
Executive Summary
Seattle, Washington-based Mirabilis Medica has received $10.5m in funding after it closed an extension to a series A financing round that initially took place last year. The financing, which adds to the $4m raised during the original round (see Clinica's Medtech Ventures No 1, p 2), was led by Arboretum Ventures. It also included investments from Split Rock Partners, Dow Venture Capital and an individual investor. Mirabilis is seeking funds to back the continued development and testing of its image-guided, high-intensity focused ultrasound (HIFU) system for treating gynaecological diseases.